Ipg Investment Advisors LLC Kintara Therapeutics, Inc. Transaction History

Ipg Investment Advisors LLC

  • $458 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021
SELL
$1.26 - $1.72 $32,760 - $44,720
-26,000 Closed
0 $0
Q3 2020

Nov 05, 2020
BUY
$0.63 - $1.7 $16,380 - $44,200
26,000 New
26,000 $36.4 Million

About Kintara Therapeutics, Inc.

KTRA Quotes by TradingView
  • Ticker KTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,807,296
  • Market Cap $17.8M
  • Description
  • Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...
More about KTRA
Track This Portfolio

Track Ipg Investment Advisors LLC Portfolio

Follow Ipg Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipg Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ipg Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email